- Home
- WRB vs BNTX Comparison
WRB vs BNTX Comparison
Compare WRB & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRB
- BNTX
- Stock Information
- Founded
- WRB 1967
- BNTX 2008
- Country
- WRB United States
- BNTX Germany
- Employees
- WRB N/A
- BNTX N/A
- Industry
- WRB Property-Casualty Insurers
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WRB Finance
- BNTX Health Care
- Exchange
- WRB Nasdaq
- BNTX Nasdaq
- Market Cap
- WRB 28.0B
- BNTX 26.4B
- IPO Year
- WRB N/A
- BNTX 2019
- Fundamental
- Price
- WRB $73.12
- BNTX $96.31
- Analyst Decision
- WRB Hold
- BNTX Strong Buy
- Analyst Count
- WRB 12
- BNTX 18
- Target Price
- WRB $71.18
- BNTX $139.49
- AVG Volume (30 Days)
- WRB 1.6M
- BNTX 1.2M
- Earning Date
- WRB 10-20-2025
- BNTX 11-03-2025
- Dividend Yield
- WRB 2.20%
- BNTX N/A
- EPS Growth
- WRB 15.81
- BNTX N/A
- EPS
- WRB 4.40
- BNTX N/A
- Revenue
- WRB $14,286,154,000.00
- BNTX $3,380,387,551.00
- Revenue This Year
- WRB $8.65
- BNTX N/A
- Revenue Next Year
- WRB $7.11
- BNTX $13.50
- P/E Ratio
- WRB $16.60
- BNTX N/A
- Revenue Growth
- WRB 11.41
- BNTX 6.98
- 52 Week Low
- WRB $55.80
- BNTX $81.20
- 52 Week High
- WRB $76.38
- BNTX $129.27
- Technical
- Relative Strength Index (RSI)
- WRB 56.56
- BNTX 38.20
- Support Level
- WRB $70.43
- BNTX $90.12
- Resistance Level
- WRB $73.32
- BNTX $100.84
- Average True Range (ATR)
- WRB 1.22
- BNTX 4.19
- MACD
- WRB -0.00
- BNTX -0.53
- Stochastic Oscillator
- WRB 70.60
- BNTX 24.99
About WRB W.R. Berkley Corporation
W.R. Berkley is an insurance holding company with a host of subsidiaries that primarily underwrite commercial casualty insurance. The firm specializes in niche products that include various excess and surplus lines, workers' compensation insurance, self-insurance consulting, reinsurance, and regional commercial lines for small and midsize businesses.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.